Evidence map›Paper›PMID 34092006›Full record

ArticleAging cell2021

Chronological and biological aging of the human left ventricular myocardium: Analysis of microRNAs contribution.

Estel Ramos-Marquès, Laura García-Mendívil, María Pérez-Zabalza, Hazel Santander-Badules, Sabarathinam Srinivasan, Juan Carlos Oliveros, Rafael Torres-Pérez, Alberto Cebollada, José María Vallejo-Gil, Pedro Carlos Fresneda-Roldán and 18 more

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Metabolic Changes in Cardiac Aging.Reviews in cardiovascular medicine · 2023
    Review
  4. Role of endocrine PACAP in age-related diseases.Frontiers in endocrinology · 2023
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 7 institutions in 3 countries.

Estel Ramos-MarquèsBiomedical Signal Interpretation and Computational Simulation group (BSICoS), Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza, Spain.ORCID 0000-0002-9218-6062
Laura García-MendívilBiomedical Signal Interpretation and Computational Simulation group (BSICoS), Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza, Spain.ORCID 0000-0002-2954-1068
María Pérez-ZabalzaBiomedical Signal Interpretation and Computational Simulation group (BSICoS), Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza, Spain.ORCID 0000-0002-3194-7796
Hazel Santander-BadulesBiomedical Signal Interpretation and Computational Simulation group (BSICoS), Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza, Spain.ORCID 0000-0002-7827-9916
Sabarathinam SrinivasanBiomedical Signal Interpretation and Computational Simulation group (BSICoS), Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza, Spain.
Juan Carlos OliverosBioinformatics for Genomics and Proteomics, National Center of Biotechnology- Spanish National Research Council, Madrid, Spain.
Rafael Torres-PérezBioinformatics for Genomics and Proteomics, National Center of Biotechnology- Spanish National Research Council, Madrid, Spain.ORCID 0000-0002-3696-4720
Alberto CebolladaBiocomputation unit, IACS, Zaragoza, Spain.
José María Vallejo-GilDepartment of Cardiovascular Surgery, University Hospital Miguel Servet, Zaragoza, Spain.
Pedro Carlos Fresneda-RoldánDepartment of Cardiovascular Surgery, University Hospital Miguel Servet, Zaragoza, Spain.
Javier Fañanás-MastralDepartment of Cardiovascular Surgery, University Hospital Miguel Servet, Zaragoza, Spain.
Manuel Vázquez-SanchoDepartment of Cardiovascular Surgery, University Hospital Miguel Servet, Zaragoza, Spain.
Marta Matamala-AdellDepartment of Cardiovascular Surgery, University Hospital Miguel Servet, Zaragoza, Spain.
Juan Fernando Sorribas-BerjónDepartment of Cardiovascular Surgery, University Hospital Miguel Servet, Zaragoza, Spain.
Javier André Bellido-MoralesDepartment of Cardiovascular Surgery, University Hospital Miguel Servet, Zaragoza, Spain.
Francisco Javier Mancebón-SierraDepartment of Cardiovascular Surgery, University Hospital Miguel Servet, Zaragoza, Spain.
Alexánder Sebastián Vaca-NúñezDepartment of Cardiovascular Surgery, University Hospital Miguel Servet, Zaragoza, Spain.
Carlos Ballester-CuencaDepartment of Cardiovascular Surgery, University Hospital Miguel Servet, Zaragoza, Spain.
Manuel Jiménez-NavarroHeart Area, Hospital Clínico Universitario Virgen de la Victoria, CIBERCV, IBIMA, Universidad de Málaga, UMA, Málaga, Spain.ORCID 0000-0002-6759-0514
José Manuel VillaescusaUGC Heart Area, Cardiovascular Surgery Department, Hospital Universitario Virgen de la Victoria de Málaga, Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS), CIBERCV Enfermedades Cardiovasculares, Instituto de Salud Carlos III, University of Málaga, Madrid, Spain.
Elisa Garrido-HuéscarBiomedical Signal Interpretation and Computational Simulation group (BSICoS), Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza, Spain.ORCID 0000-0002-0847-066X
Margarita Segovia-RoldánBiomedical Signal Interpretation and Computational Simulation group (BSICoS), Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza, Spain.ORCID 0000-0003-0409-705X
Aida Oliván-VigueraBiomedical Signal Interpretation and Computational Simulation group (BSICoS), Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza, Spain.ORCID 0000-0001-5348-924X
Carlos Gómez-GonzálezDepartment of Pathology, San Jorge Hospital, Huesca, Spain.
Gorka MuñizDepartment of Pathology, San Jorge Hospital, Huesca, Spain.
Emiliano DiezInstitute of Experimental Medicine and Biology of Cuyo (IMBECU), CONICET, Mendoza, Argentina.ORCID 0000-0001-5163-3703
Laura OrdovásBiomedical Signal Interpretation and Computational Simulation group (BSICoS), Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza, Spain.ORCID 0000-0003-3982-1263
Esther PueyoBiomedical Signal Interpretation and Computational Simulation group (BSICoS), Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza, Spain.ORCID 0000-0002-1960-407X
Hospital Universitario Miguel Servet · ESUniversidad de Zaragoza · ESCentro Nacional de Biotecnología · ESHospital General San Jorge · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ESConsejo Nacional de Investigaciones Científicas y Técnicas · ARInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging is the main risk factor for cardiovascular diseases. In humans, cardiac aging remains poorly characterized. Most studies are based on chronological age (CA) and disregard biological age (BA), the actual physiological age (result of the aging rate on the organ structure and function), thus yielding potentially imperfect outcomes. Deciphering the molecular basis of ventricular aging, especially by BA, could lead to major progresses in cardiac research. We aim to describe the transcriptome dynamics of the aging left ventricle (LV) in humans according to both CA and BA and characterize the contribution of microRNAs, key transcriptional regulators. BA is measured using two CA-associated transcriptional markers: CDKN2A expression, a cell senescence marker, and apparent age (AppAge), a highly complex transcriptional index. Bioinformatics analysis of 132 LV samples shows that CDKN2A expression and AppAge represent transcriptomic changes better than CA. Both BA markers are biologically validated in relation to an aging phenotype associated with heart dysfunction, the amount of cardiac fibrosis. BA-based analyses uncover depleted cardiac-specific processes, among other relevant functions, that are undetected by CA. Twenty BA-related microRNAs are identified, and two of them highly heart-enriched that are present in plasma. We describe a microRNA-gene regulatory network related to cardiac processes that are partially validated in vitro and in LV samples from living donors. We prove the higher sensitivity of BA over CA to explain transcriptomic changes in the aging myocardium and report novel molecular insights into human LV biological aging. Our results can find application in future therapeutic and biomarker research.

Indexed as

AgingBiomarkersFemaleHeart VentriclesHumansMaleMicroRNAsBiomarkersMicroRNAsbiological agingbiomarkersgene regulation networkheart agingmicroRNAtranscriptomic age marker

Identifiers

PMID34092006
PMCPMC8282276
OpenAlexW3167913052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.